<?xml version="1.0" encoding="utf-8"?><rss version="2.0">
<channel>
<title>IM Vaccine</title>
<link>http://www.imvaccine.com/</link>
<description>IM Vaccine News Feed</description>
<category>vaccine, cancer, medical</category>
<generator></generator>
<webMaster>techsupport@impactcommuncations.ca</webMaster>
		<item>
		<title>Immunovaccine Signs Licensing Deal with Pfizer Animal Health to Develop a Third Livestock Vaccine</title>
		<link>http://www.imvaccine.com/releases.php?releases_id=196</link>
		<date>Tue, 9 Mar 2010 00:00:00 PST</date>
		<description>Immunovaccine Signs Licensing Deal with Pfizer Animal Health to Develop a Third Livestock Vaccine</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Appoints James Hall as New Board Member</title>
		<link>http://www.imvaccine.com/releases.php?releases_id=195</link>
		<date>Tue, 9 Mar 2010 00:00:00 PST</date>
		<description>Immunovaccine Appoints James Hall as New Board Member</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Presents Results for an Enhanced Anthrax Vaccine Candidate</title>
		<link>http://www.imvaccine.com/releases.php?releases_id=194</link>
		<date>Tue, 9 Mar 2010 00:00:00 PST</date>
		<description>Immunovaccine Presents Results for an Enhanced Anthrax Vaccine Candidate</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Provides Corporate Update</title>
		<link>http://www.imvaccine.com/releases.php?releases_id=192</link>
		<date>Tue, 9 Mar 2010 00:00:00 PST</date>
		<description>Immunovaccine Provides Corporate Update</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Hires Investor Relations Firm</title>
		<link>http://www.imvaccine.com/releases.php?releases_id=191</link>
		<date>Tue, 9 Mar 2010 00:00:00 PST</date>
		<description>Immunovaccine Hires Investor Relations Firm</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Grants Stock Options</title>
		<link>http://www.imvaccine.com/releases.php?releases_id=190</link>
		<date>Tue, 9 Mar 2010 00:00:00 PST</date>
		<description>Immunovaccine Grants Stock Options</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Receives Clearance from FDA to Proceed with Phase 1 Clinical Trial for its Therapeutic Cancer Vaccine</title>
		<link>http://www.imvaccine.com/releases.php?releases_id=189</link>
		<date>Tue, 9 Mar 2010 00:00:00 PST</date>
		<description>Immunovaccine Receives Clearance from FDA to Proceed with Phase 1 Clinical Trial for its Therapeutic Cancer Vaccine</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Licenses Vaccine Platform to Pfizer Animal Health</title>
		<link>http://www.imvaccine.com/releases.php?releases_id=188</link>
		<date>Tue, 9 Mar 2010 00:00:00 PST</date>
		<description>Immunovaccine Licenses Vaccine Platform to Pfizer Animal Health</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Inc. Signs Collaboration Agreement with National Cancer Institute</title>
		<link>http://www.imvaccine.com/releases.php?releases_id=182</link>
		<date>Tue, 9 Mar 2010 00:00:00 PST</date>
		<description>Immunovaccine Inc. Signs Collaboration Agreement with National Cancer Institute</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Inc. Signs Cato Research Canada, Inc. as Clinical Trial CRO</title>
		<link>http://www.imvaccine.com/releases.php?releases_id=181</link>
		<date>Tue, 9 Mar 2010 00:00:00 PST</date>
		<description>Immunovaccine Inc. Signs Cato Research Canada, Inc. as Clinical Trial CRO</description>
		<author></author>
		<category></category>
		</item>
		 </channel>
</rss>

